Compounds > dichlorolissoclimide
Page last updated: 2024-09-03

dichlorolissoclimide and Lung Neoplasms

dichlorolissoclimide has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biard, JF; Charrier, J; Malochet, C; Meflah, K; Riou, D; Roussakis, C; Verbist, JF1
Biard, JF; Débitus, C; Malochet-Grivois, C; Riou, D; Robillard, N; Roussakis, C; Verbist, JF1

Other Studies

2 other study(ies) available for dichlorolissoclimide and Lung Neoplasms

ArticleYear
Chemotherapeutic inhibition of erb-B2 oncogene expression on a non-small-cell cancer line (NSCLC-N6) by marine substances.
    Anti-cancer drug design, 1994, Volume: 9, Issue:2

    Topics: Acetamides; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Diterpenes; ErbB Receptors; Ethers, Cyclic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Oncogenes; Proto-Oncogene Proteins; Pyrans; Receptor, ErbB-2; Spiro Compounds; Succinimides; Tumor Cells, Cultured

1994
Effects in vitro of two marine substances, chlorolissoclimide and dichlorolissoclimide, on a non-small-cell bronchopulmonary carcinoma line (NSCLC-N6).
    Anti-cancer drug design, 1992, Volume: 7, Issue:6

    Topics: Carcinoma, Non-Small-Cell Lung; Diterpenes; Drug Screening Assays, Antitumor; Flow Cytometry; G1 Phase; Humans; Lung Neoplasms; Succinimides; Tumor Cells, Cultured

1992